Sanofi Aktie
84,86
EUR
-0,52
EUR
-0,61
%
85,28
EUR
+0,56
EUR
+0,66
%
Kursziele der Sanofi-Aktie in EUR
Das durchschnittliche Kursziel beinhaltet alle Analysen eines Analysten und nicht nur die jeweils aktuellste Analyse, die im Chart dargestellt wird.
Diese Analysten bewerten die Sanofi-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| Deutsche Bank AG | 100,00 EUR | +17,26% | 23.07.2025 | |
| Bernstein Research | 124,00 EUR | +45,40% | 22.07.2025 | |
| JP Morgan Chase & Co. | 110,00 EUR | +28,99% | 17.07.2025 | |
| UBS AG | 115,00 EUR | +34,85% | 11.07.2025 | |
| Goldman Sachs Group Inc. | 103,00 EUR | +20,78% | 03.07.2025 | |
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 118,00 EUR | +38,37% | 03.07.2025 | |
| Barclays Capital | 115,00 EUR | +34,85% | 02.07.2025 | |
| Jefferies & Company Inc. | 120,00 EUR | +40,71% | 05.06.2025 | |
| DZ BANK | - | - | 25.04.2025 |
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Allergan Inc. | 0 | 0 | 0 | - | - |
| Amgen Inc. | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 5 | 3 | 0 | 136,58 GBP | - |
| Bayer | 2 | 7 | 0 | 26,86 EUR | -7,20% |
| BioNTech (ADRs) | 4 | 2 | 0 | 135,33 USD | +18,12% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| CureVac | 0 | 2 | 0 | - | - |
| EVOTEC SE | 2 | 3 | 0 | 9,60 EUR | +40,76% |
| GSK PLC Registered Shs | 1 | 6 | 1 | 16,14 GBP | +15,82% |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 7 | 1 | 0 | 163,50 EUR | +43,86% |
| Moderna Inc | 0 | 2 | 1 | 67,33 USD | +97,97% |
| MorphoSys | 0 | 0 | 0 | - | - |
| Mylan N.V. | 0 | 0 | 0 | - | - |
| Novartis AG | 3 | 5 | 1 | 98,62 CHF | +5,82% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 3 | 4 | 0 | 29,17 USD | +15,07% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 6 | 3 | 0 | 113,12 EUR | +31,84% |
| Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
| Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
| Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
| STADA | 0 | 0 | 0 | - | - |
| Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 0 | 0 | 0 | - | - |
| Valneva | 0 | 0 | 0 | - | - |
| Warner Chilcott plc | 0 | 0 | 0 | - | - |